11.4 ± 0.1 kg |
Aflatoxins - 140 or 280 μg/kg |
28 |
Decreased weight gain and altered humoral and cellular immune responses |
(244) |
14.2 ± 3.0 kg |
Aflatoxins - 250 or 500 μg/kg |
70 |
Reduced ADG and ADFI |
(245) |
27 day |
Deoxynivalenol - 3.2 mg/kg |
34 |
Reduced ADG during the last 13 day |
(123) |
10.3 ± 0.2 kg |
Deoxynivalenol - 4 mg/kg |
21 |
Reduced ADG, ADFI, and growth efficiency |
(246) |
8.9 kg |
Fumonisins - 7.2, 14.7, 21.9, 32.7, or 35.1 mg/kg |
28 |
Decreased ADG, ADFI, and growth efficiency increased the serum sphinganine-to-sphingosine ratio |
(247) |
28 day |
Fumonisins - 3.7 mg/kg |
28 |
Increased the serum sphinganine-to-sphingosine ratio and altered heart and intestine morphology |
(248) |
12–14 kg |
Orchratoxin A - 800 μg/kg |
84 |
Decreased BW and increased kidney weight |
(249) |
21 day |
Zearalenone - 1 mg/kg |
22 |
Had no effect on growth performance; however negative effect was shown on genital organs and serum hormones in gilts |
(250) |
10.4 ± 1.2 kg |
Zearalenone - 1.1, 2.0 or 3.2 mg/kg |
18 |
Negatively affected immune function in gilts |
(251) |
21 day |
Aflatoxins - 180 ug/kg; Fumonisins - 9 mg/kg; Deoxynivalenol - 1 mg/kg |
48 |
Reduced BW, ADG, ADFI, and growth efficiency |
(2) |
6.8 ± 0.1 kg |
Aflatoxins - 2,778 μg/kg; Fumonisins - 170 mg/kg; Zearalenone - 1 mg/kg |
33 |
Reduced ADG |
(10) |